NASDAQ:SNDX
Syndax Pharmaceuticals Inc (SNDX) receives a Buy rating from H.C. Wainwright
Daniel Torres
Syndax Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
H.C. Wainwright’s latest rating for SNDX stock
Roman Campbell
Syndax Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
SNDX stock rated a Buy by H.C. Wainwright
Daniel Torres
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
Recent Insider Activity Could Benefit Syndax Pharmaceuticals Inc (SNDX)
Daniel Torres
Syndax Pharmaceuticals Inc’s filing revealed that its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 million ...
A company insider recently sold 157,307 shares of Syndax Pharmaceuticals Inc [SNDX]. Should You also Consider to Sale?
Anna Perez
In a filing, Syndax Pharmaceuticals Inc revealed its Chief Executive Officer Metzger Michael A unloaded Company’s shares for reported $2.58 ...
